J. Martin Carroll - 10 May 2023 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Director
Signature
/s/ Sheldon L. Koenig, by power of attorney
Issuer symbol
ESPR
Transactions as of
10 May 2023
Net transactions value
+$48,831
Form type
4
Filing time
11 May 2023, 16:11:27 UTC
Previous filing
31 Oct 2022
Next filing
16 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Purchase $12,545 +8,409 +168% $1.49 13,409 10 May 2023 Direct
transaction ESPR Common Stock Purchase $36,285 +23,091 +172% $1.57 36,500 11 May 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.